These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35641861)

  • 1. A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation.
    Destere A; Marquet P; Gandonnière CS; Åsberg A; Loustaud-Ratti V; Carrier P; Ehrmann S; Guellec CB; Premaud A; Woillard JB
    Clin Pharmacokinet; 2022 Aug; 61(8):1157-1165. PubMed ID: 35641861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction.
    Destere A; Marquet P; Labriffe M; Drici MD; Woillard JB
    Pharm Res; 2023 Apr; 40(4):951-959. PubMed ID: 36991227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles.
    Labriffe M; Woillard JB; Debord J; Marquet P
    CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):1018-1028. PubMed ID: 35599364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A machine learning approach to predict daptomycin exposure from two concentrations based on Monte Carlo simulations.
    Codde C; Rivals F; Destere A; Fromage Y; Labriffe M; Marquet P; Benoist C; Ponthier L; Faucher J-F; Woillard J-B
    Antimicrob Agents Chemother; 2024 May; 68(5):e0141523. PubMed ID: 38501807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the glomerular filtration rate (GFR) in kidney transplant recipients using Bayesian estimation of the iohexol clearance.
    Riff C; Besombes J; Gatault P; Barbet C; Büchler M; Blasco H; Halimi JM; Barin-Le Guellec C; Benz-de Bretagne I
    Clin Chem Lab Med; 2020 Mar; 58(4):577-587. PubMed ID: 31926067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients.
    Destere A; Salmon Gandonnière C; Åsberg A; Loustaud-Ratti V; Carrier P; Ehrmann S; Barin-Le Guellec C; Marquet P; Woillard JB
    Br J Clin Pharmacol; 2022 Jun; 88(6):2793-2801. PubMed ID: 34951499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients.
    Benz-de Bretagne I; Le Guellec C; Halimi JM; Gatault P; Barbet C; Alnajjar A; Büchler M; Lebranchu Y; Andres CR; Vourcʼh P; Blasco H
    Ther Drug Monit; 2012 Jun; 34(3):289-97. PubMed ID: 22585184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: The example of tacrolimus.
    Woillard JB; Labriffe M; Prémaud A; Marquet P
    Pharmacol Res; 2021 May; 167():105578. PubMed ID: 33775863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation Setting.
    Zwart TC; de Vries APJ; Engbers AGJ; Dam RE; van der Boog PJM; Swen JJ; Keizer RJ; Dalton RN; Guchelaar HJ; de Fijter JW; Moes DJAR
    Clin Pharmacokinet; 2021 Sep; 60(9):1201-1215. PubMed ID: 33864239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Machine Learning Approach to Predict Interdose Vancomycin Exposure.
    Bououda M; Uster DW; Sidorov E; Labriffe M; Marquet P; Wicha SG; Woillard JB
    Pharm Res; 2022 Apr; 39(4):721-731. PubMed ID: 35411504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Machine Learning Approach to Estimate the Glomerular Filtration Rate in Intensive Care Unit Patients Based on Plasma Iohexol Concentrations and Covariates.
    Woillard JB; Salmon Gandonnière C; Destere A; Ehrmann S; Merdji H; Mathonnet A; Marquet P; Barin-Le Guellec C
    Clin Pharmacokinet; 2021 Feb; 60(2):223-233. PubMed ID: 32794122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
    Hughes JH; Keizer RJ
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancement of pharmacokinetic models of iohexol in patients aged 70 years or older with impaired kidney function.
    Taubert M; Schaeffner E; Martus P; van der Giet M; Fuhr U; Lösment A; Ebert N
    Sci Rep; 2021 Nov; 11(1):22656. PubMed ID: 34811403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks E; Tett SE; Isbel NM; Staatz CE
    Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance.
    Åsberg A; Bjerre A; Almaas R; Luis-Lima S; Robertsen I; Salvador CL; Porrini E; Schwartz GJ; Hartmann A; Bergan S
    Kidney Int Rep; 2020 Feb; 5(2):189-198. PubMed ID: 32043033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
    Han K; Bies R; Johnson H; Capitano B; Venkataramanan R
    Clin Pharmacokinet; 2011 Mar; 50(3):201-14. PubMed ID: 21294597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Bayesian estimation of pharmacokinetic parameters.
    Tsuchiwata S; Mihara K; Yafune A; Ogata H
    Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic Acid Exposure Prediction Using Machine Learning.
    Woillard JB; Labriffe M; Debord J; Marquet P
    Clin Pharmacol Ther; 2021 Aug; 110(2):370-379. PubMed ID: 33624286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.